Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

The Role of Glial Cells in Drug Abuse.

Miguel-Hidalgo JJ.

Curr Drug Abuse Rev. 2009;2(1):76-82.

2.

The role of glial cells in drug abuse.

Miguel-Hidalgo JJ.

Curr Drug Abuse Rev. 2009 Jan;2(1):72-82. Review.

PMID:
19630738
3.

Glutamatergic synaptic plasticity in the mesocorticolimbic system in addiction.

van Huijstee AN, Mansvelder HD.

Front Cell Neurosci. 2015 Jan 20;8:466. doi: 10.3389/fncel.2014.00466. eCollection 2014. Review.

4.

Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity?

Niciu MJ, Henter ID, Sanacora G, Zarate CA Jr.

World J Biol Psychiatry. 2014 Jan;15(1):2-16. doi: 10.3109/15622975.2013.829585. Epub 2013 Sep 12. Review.

5.

Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse.

Lacagnina MJ, Rivera PD, Bilbo SD.

Neuropsychopharmacology. 2017 Jan;42(1):156-177. doi: 10.1038/npp.2016.121. Epub 2016 Jul 11.

PMID:
27402494
6.

Multifunctional role of astrocytes as gatekeepers of neuronal energy supply.

Stobart JL, Anderson CM.

Front Cell Neurosci. 2013 Apr 10;7:38. doi: 10.3389/fncel.2013.00038. eCollection 2013.

7.

Repeated alcohol administration during adolescence causes changes in the mesolimbic dopaminergic and glutamatergic systems and promotes alcohol intake in the adult rat.

Pascual M, Boix J, Felipo V, Guerri C.

J Neurochem. 2009 Feb;108(4):920-31. doi: 10.1111/j.1471-4159.2008.05835.x. Epub 2008 Dec 10.

8.

Glutamatergic transmission in drug reward: implications for drug addiction.

D'Souza MS.

Front Neurosci. 2015 Nov 5;9:404. doi: 10.3389/fnins.2015.00404. eCollection 2015. Review.

9.

Drug addiction. Part II. Neurobiology of addiction.

Vetulani J.

Pol J Pharmacol. 2001 Jul-Aug;53(4):303-17. Review.

10.

Astrocytic control of synaptic transmission and plasticity: a target for drugs of abuse?

Haydon PG, Blendy J, Moss SJ, Rob Jackson F.

Neuropharmacology. 2009;56 Suppl 1:83-90. doi: 10.1016/j.neuropharm.2008.06.050. Epub 2008 Jul 3. Review.

11.

Smoking and alcoholism target genes associated with plasticity and glutamate transmission in the human ventral tegmental area.

Flatscher-Bader T, Zuvela N, Landis N, Wilce PA.

Hum Mol Genet. 2008 Jan 1;17(1):38-51. Epub 2007 Oct 10.

PMID:
17928304
12.

Reward Circuitry in Addiction.

Cooper S, Robison AJ, Mazei-Robison MS.

Neurotherapeutics. 2017 Jul;14(3):687-697. doi: 10.1007/s13311-017-0525-z. Review.

PMID:
28324454
13.

Dynamic changes in dopaminergic neurotransmission induced by a low concentration of bisphenol-A in neurones and astrocytes.

Miyatake M, Miyagawa K, Mizuo K, Narita M, Suzuki T.

J Neuroendocrinol. 2006 Jun;18(6):434-44.

PMID:
16684133
14.

Glutamatergic substrates of drug addiction and alcoholism.

Gass JT, Olive MF.

Biochem Pharmacol. 2008 Jan 1;75(1):218-65. Epub 2007 Jun 30. Review.

15.
16.

Alterations in Striatal Circuits Underlying Addiction-Like Behaviors.

Kim HJ, Lee JH, Yun K, Kim JH.

Mol Cells. 2017 Jun 30;40(6):379-385. doi: 10.14348/molcells.2017.0088. Epub 2017 Jul 12. Review.

17.

Synaptic plasticity in drug reward circuitry.

Winder DG, Egli RE, Schramm NL, Matthews RT.

Curr Mol Med. 2002 Nov;2(7):667-76. Review.

PMID:
12420805
18.

Drug dependence as a disorder of neural plasticity: focus on dopamine and glutamate.

Pulvirenti L, Diana M.

Rev Neurosci. 2001;12(2):141-58. Review.

PMID:
11392455
19.

The neurobiology of addictive disorders.

Ross S, Peselow E.

Clin Neuropharmacol. 2009 Sep-Oct;32(5):269-76. Review.

PMID:
19834992
20.

Influence of neurotrophic factors on morphine- and cocaine-induced biochemical changes in the mesolimbic dopamine system.

Berhow MT, Russell DS, Terwilliger RZ, Beitner-Johnson D, Self DW, Lindsay RM, Nestler EJ.

Neuroscience. 1995 Oct;68(4):969-79.

PMID:
8545003

Supplemental Content

Support Center